TG Therapeutics, Inc. TGTX
$55.98
-1.28%
at last close
Financials (TTM)
- Revenue
- $799.54 million
- Net Income
- $441.49 million
- Net Margin
- 55.22%
- Return on Equity
- 73.08%
- Debt-to-Equity
- —
- P/E Ratio
- 20.36
- Price / Book
- 14.19
- Price / Sales
- 10.72
Over the trailing twelve months, TG Therapeutics, Inc. generated revenue of $799.54 million and net income of $441.49 million, a net margin of 55.22%.
At the last closing price of $55.98, TGTX trades at 20.36 times trailing earnings and 10.72 times sales, with a market capitalization of $8.57 billion.
Key Stats
- Last Close
- $55.98
- Market Cap
- $8.57 billion
- 52-Week Range
- $25.28 – $59.30
- Average Volume
- 2.21 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.